Efficacy and Safety of Diclofenac 1.16% Gel in Subjects With Acute Neck Pain

• Status: Completed
• Trial end date: 2011-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the efficacy and safety of diclofenac 1.16% gel compared with placebo applied four times a day in subjects with acute neck pain.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novartis
• Treatments: Diclofenac

Criteria

Inclusion Criteria:

• Male or female subjects, age range 18 and over.

• Patient with acute neck pain meeting baseline pain intensity level and duration

Exclusion Criteria:

• Pain medication was taken within the 6 hours that precede randomization.

• Patient with chronic neck pain as defined as pain for 3 months or longer

• Any neck pain that is attributable to any organic disease, such as prolapsed disc, spondylolisthesis, osteomalacia, inflammatory arthritis, metabolic, neurological diseases or tumors.

• Any recent strains of the neck muscles documented by the clinical evaluation and anamnesis